Comparative analysis of persistence and remission with guselkumab versus secukinumab and ixekizumab in the United States

Comparative analysis of persistence and remission with guselkumab versus secukinumab and ixekizumab in the United States

Purpose: Real-world data comparing long-term performance of interleukin (IL)-23 and IL-17 inhibitors in psoriasis are limited. This study compared treatment persistence and remission among patients initiating guselkumab versus IL-17 inhibitors.Methods: Adults with psoriasis initiating guselkumab, se...

Full description

Saved in:
Bibliographic Details
Main Authors: Maryia Zhdanava, Timothy Fitzgerald, Dominic Pilon, Rachel E. Teneralli, Aditi Shah, Lilian Diaz, Patrick Lefebvre, Steven R. Feldman
Format: Article
Language:English
Published: Taylor & Francis Group 2024-12-01
Series:Journal of Dermatological Treatment
Subjects:
Psoriasis
biologics
guselkumab
treatment discontinuation
persistence
remission
Online Access:https://www.tandfonline.com/doi/10.1080/09546634.2024.2349658
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items